// App-Quantinova.ai

Su1499 : Early Use of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Primary Prophylaxis of Gastric Variceal Bleeding: Evaluation of Effectiveness and Effect on Global Liver Function

Researchers

Presenter

  • Hussein Abidali

Principal Investigators

  • Mark R. Pedersen

  • Myunghan Choi

  • Anil B. Seetharam

Medical Centers

  • Transplant and Advanced Liver Disease Center, Banner University Medical Center, Phoenix, Arizona, United States

  • Nursing and Healthcare Innovation, Arizona State University, Tempe, Arizona, United States

  • Internal Medicine, Banner Baywood Medical Center, Phoenix, Arizona, United States

  • The University of Arizona College of Medicine, Tucson, Arizona, United States

  • Gastroenterology, Phoenix VA Medical Center, Phoenix, Arizona, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • End-stage liver disease

  • Esophageal varices

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • Creatinine

  • RAB3D, Member RAS Oncogene Family

  • Body mass index

  • Bilirubin

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved